Eyez,Inc.
Eyez,Inc. (5242.T) Financial Performance & Income Statement Overview
Analyze Eyez,Inc. (5242.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Eyez,Inc. (5242.T) Income Statement & Financial Overview
Analyze Eyez,Inc.’s 5242.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $248.00M | $238.00M | $283.48M | $267.18M |
| Cost of Revenue | $19.00M | $23.00M | $28.15M | $17.54M |
| Gross Profit | $229.00M | $215.00M | $255.33M | $249.64M |
| Gross Profit Ratio | $0.92 | $0.90 | $0.90 | $0.93 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $215.00M | $230.00M | $1000.00 | $237.00M |
| Operating Expenses | $215.00M | $231.00M | $233.64M | $237.15M |
| Total Costs & Expenses | $234.00M | $254.00M | $261.79M | $254.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $2000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.25M | $1.50M | $1.52M | $3.40M |
| EBITDA | $15.25M | -$13.50M | $23.20M | $15.88M |
| EBITDA Ratio | $0.06 | -$0.06 | $0.08 | $0.06 |
| Operating Income | $14.00M | -$16.00M | $21.69M | $12.48M |
| Operating Income Ratio | $0.06 | -$0.07 | $0.08 | $0.05 |
| Other Income/Expenses (Net) | $1.00M | $1.00M | $1.52M | $3.40M |
| Income Before Tax | $15.00M | -$15.00M | $23.20M | $15.88M |
| Income Before Tax Ratio | $0.06 | -$0.06 | $0.08 | $0.06 |
| Income Tax Expense | $3.00M | $4.00M | $7.60M | $5.17M |
| Net Income | $12.00M | -$11.00M | $15.60M | $10.72M |
| Net Income Ratio | $0.05 | -$0.05 | $0.06 | $0.04 |
| EPS | $10.89 | -$10.83 | $14.64 | $10.60 |
| Diluted EPS | $10.89 | -$10.83 | $14.64 | $10.10 |
| Weighted Avg Shares Outstanding | $1.10M | $1.02M | $1.09M | $1.01M |
| Weighted Avg Shares Outstanding (Diluted) | $1.10M | $1.02M | $1.09M | $1.06M |
The company's financials show resilient growth, with revenue advancing from $267.18M in Q1 2024 to $248.00M in Q4 2024. Gross profit remained healthy with margins at 92% in Q4 2024 compared to 93% in Q1 2024. Operating income hit $14.00M last quarter, sustaining a consistent 6% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $15.25M. Net income rose to $12.00M, while earnings per share reached $10.89. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan